Sernova Biotherapeutics Inc
SEOVF
$0.12
$0.003.05%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.62% | -98.34% | -76.56% | -92.82% | -69.74% |
| Total Receivables | -59.09% | -46.63% | -64.89% | -66.47% | -71.79% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.67% | -78.94% | -28.69% | -9.90% | -3.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -91.97% | -91.99% | -72.09% | -88.81% | -69.33% |
|
|
|||||
| Total Current Assets | -91.97% | -91.99% | -72.09% | -88.81% | -69.33% |
| Net Property, Plant & Equipment | -97.89% | -79.20% | -22.72% | -27.55% | 63.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.56% | -0.19% | -0.55% | -7.53% | -13.93% |
| Total Assets | -89.91% | -87.81% | -67.25% | -84.68% | -66.06% |
|
|
|||||
| Total Accounts Payable | 1.88% | 4.01% | 18.41% | 36.20% | 150.88% |
| Total Accrued Expenses | 26.61% | 85.27% | 14.33% | -11.15% | 5.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -34.81% | 19.47% | 11.38% | -25.71% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 23.20% | 24.67% | 38.48% | 33.96% | 107.97% |
|
|
|||||
| Total Current Liabilities | 23.20% | 24.67% | 38.48% | 33.96% | 107.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -93.45% | -21.72% | -25.53% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.44% | 26.45% | 41.31% | 31.75% | 112.84% |
|
|
|||||
| Common Stock & APIC | 1.70% | 4.46% | 4.25% | -3.11% | 4.77% |
| Retained Earnings | -9.85% | -12.52% | -15.32% | -12.78% | -26.82% |
| Treasury Stock & Other | 1,451.82% | -- | -- | -- | -- |
| Total Common Equity | -92.46% | -94.33% | -273.40% | -532.29% | -203.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.46% | -94.33% | -273.40% | -532.29% | -203.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.46% | -94.33% | -273.40% | -532.29% | -203.19% |
|
|
|||||